Dr. Gonzalez shares 126-week topline results from the REMAIN study, assessing optogenetic therapy MCO-010 (Nanoscope Therapeutics).

The long-term outcomes after primary scleral buckling procedures for rhegmatogenous retinal detachments showed high anatomic ...

A new Alcon-sponsored survey conducted by Wakefield Research uncovered a gap between parental recognition of the role of ...

The first half of 2026 brought a steady drumbeat of regulatory and clinical news across the diabetic eye disease space, from ...

Esen Akpek, MD, on dry eye's emotional and vision-related toll, its hidden autoimmune links, and when to move patients beyond ...

Ocular Surface Disease | Clinical | The Eye Care Network delivers clinical news, expert interviews, and conference coverage across ophthalmology, retina, and optometry — uniting Ophthalmology Times, ...

Alcon and RxSight, Inc have announced a non-exclusive collaboration to jointly develop adjustable presbyopia-correcting ...

Pooling data from 317 published articles covering 690 individual patient cases, the review's authors searched PubMed, Scopus and the Cochrane Library for reports of noninfectious uveitis linked to a ...

Cascade Prodrug and Uneedle are partnering to test suprachoroidal delivery of CPD100 using Uneedle's Bella-Vue microneedle system for the treatment of wet AMD. Cascade Prodrug and Uneedle are ...

All syringes used for intravitreal injections have pros and cons. Some recently marketed and forthcoming products are coming closer to meeting “ideal” criteria.

Please check back later for more content.

The FDA issued a nationwide recall of a steroid eye drop. The US Food and Drug Administration (FDA) announced a nationwide recall of millions of bottles of prescription steroid eye drops because of ...